APA (7th ed.) Citation

Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., . . . Minassian, A. M. (2020). Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet, 396(10249), 467. https://doi.org/10.1016/S0140-6736(20)31604-4

Chicago Style (17th ed.) Citation

Folegatti, Pedro M., et al. "Safety and Immunogenicity of the ChAdOx1 NCoV-19 Vaccine Against SARS-CoV-2: A Preliminary Report of a Phase 1/2, Single-blind, Randomised Controlled Trial." Lancet 396, no. 10249 (2020): 467. https://doi.org/10.1016/S0140-6736(20)31604-4.

MLA (9th ed.) Citation

Folegatti, Pedro M., et al. "Safety and Immunogenicity of the ChAdOx1 NCoV-19 Vaccine Against SARS-CoV-2: A Preliminary Report of a Phase 1/2, Single-blind, Randomised Controlled Trial." Lancet, vol. 396, no. 10249, 2020, p. 467, https://doi.org/10.1016/S0140-6736(20)31604-4.